Peer Reviewed Publications

PEER REVIEWED PUBLICATIONS:

89. Wilcox A, Sartor A, Menderes G.

Case report: Robotic lymph node resection off the aortic bifurcation for presumed recurrence management of advanced ovarian cancer.

Int J Surg Case Rep. 2023 Apr;105:108003. doi: 10.1016/j.ijscr.2023.108003. Epub 2023 Mar 23.

PMID: 37018944

88. Ruhotina M, Kukla J, Wilcox A, Murphy C, Menderes G.

Primary uterine osteosarcoma arising in a leiomyoma with rapid local recurrence: A case report.

Gynecol Oncol Rep. 2022 Nov 11;44:101102. doi: 10.1016/j.gore.2022.101102. eCollection 2022 Dec.

PMID: 36405307

87. Yadav G, Roque DM, Bellone S, Manavella DD, Hartwich TMP, Zipponi M, Harold J, Tymon-Rosario J, Mutlu L, Altwerger G, Menderes G, Ratner E, Buza N, Hui P, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Alexandrov LB, Santin AD.

Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.

Gynecol Oncol. 2022 Aug;166(2):351-357. doi: 10.1016/j.ygyno.2022.05.021. Epub 2022 May 28.

PMID: 35641325

86. Tymon-Rosario JR, Manara P, Manavella DD, Bellone S, Hartwich TMP, Harold J, Yang-Hartwich Y, Zipponi M, Choi J, Jeong K, Mutlu L, Yang K, Altwerger G, Menderes G, Ratner E, Huang GS, Clark M, Andikyan V, Azodi M, Schwartz PE, Alexandrov LB, Santin AD.

Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.

Gynecol Oncol. 2022 Jul;166(1):117-125. doi: 10.1016/j.ygyno.2022.05.005. Epub 2022 May 20.

PMID: 35599167

85. Mokhtech M, Gao SJ, Kassick M, Menderes G, Damast S.

Declining use of inguinofemoral lymphadenectomy in the treatment of clinically negative, pathologic node positive vulvar cancer.

Gynecol Oncol. 2022 Jul;166(1):61-68. doi: 10.1016/j.ygyno.2022.05.001. Epub 2022 May 9.

PMID: 35550710

84. Mutlu L, Tymon-Rosario J, Harold J, Menderes G.

Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.

Expert Rev Anticancer Ther. 2022 Jun;22(6):633-645. doi: 10.1080/14737140.2022.2075348. Epub 2022 May 23.

PMID: 35533682

83. Roque DM, Siegel ER, Buza N, Bellone S, Silasi DA, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Rao GG, Reader JC, Hui P, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Santin AD.

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Br J Cancer. 2022 Jun;126(12):1695-1703. doi: 10.1038/s41416-022-01717-6. Epub 2022 Feb 11.

PMID: 35149854

82. Yadav G, Roque DM, Bellone S, Manavella DD, Hartwich TMP, Zipponi M, Harold J, Tymon-Rosario J, Mutlu L, Altwerger G, Menderes G, Ratner E, Buza N, Hui P, Huang GS, Andikyan V, Clark M, Azodi M, Schwartz PE, Alexandrov LB, Santin AD.

Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.

Gynecol Oncol. 2022 May 28:S0090-8258(22)00332-8. doi: 10.1016/j.ygyno.2022.05.021. Online ahead of print.

PMID: 35641325

81. Harold J, Murphy C, Tymon-Rosario J, Menderes G.

Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus.

Gynecol Oncol Rep. 2022 Mar 16;40:100959. doi: 10.1016/j.gore.2022.100959. eCollection 2022 Apr.

PMID: 35372655

80. Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD.

A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.

Cancer. 2021 Dec 7. doi: 10.1002/cncr.34025. Online ahead of print.

PMID: 34875107

79. Li JY, Arkfeld CK, Tymon-Rosario J, Webster E, Schwartz P, Damast S, Menderes G.

An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.

J Gynecol Oncol. 2021 Nov 30. doi: 10.3802/jgo.2022.33.e13. Online ahead of print.

PMID: 34910394

78. Tymon-Rosario J, Bonazzoli E, Bellone S, Manzano A, Pelligra S, Guglielmi A, Gnutti B, Nagarkatti N, Zeybek B, Manara P, Zammataro L, Harold J, Mauricio D, Buza N, Hui P, Altwerger G, Menderes G, Ratner E, Clark M, Andikyan V, Huang GS, Silasi DA, Azodi M, Schwartz PE, Santin AD.

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.

Gynecol Oncol. 2021 Nov;163(2):334-341. doi: 10.1016/j.ygyno.2021.08.014. Epub 2021 Aug 25.

PMID: 34452746

77. Zeybek B, Webster E, Pogosian N, Tymon-Rosario J, Balch A, Altwerger G, Clark M, Menderes G, Huang G, Azodi M, Ratner ES, Schwartz PE, Santin AD, Andikyan V.

Financial toxicity in patients with gynecologic malignancies: a cross sectional study.

J Gynecol Oncol. 2021 Nov;32(6):e87. doi: 10.3802/jgo.2021.32.e87. Epub 2021 Jul 23.

PMID: 34431257

76. Tymon-Rosario J, Siegel ER, Bellone S, Harold J, Adjei N, Zeybek B, Mauricio D, Altwerger G, Menderes G, Ratner E, Clark M, Andikyan V, Huang GS, Azodi M, Schwartz PE, Fader AN, Santin AD.

Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.

Gynecol Oncol. 2021 Oct;163(1):93-99. doi: 10.1016/j.ygyno.2021.07.033. Epub 2021 Aug 6.

PMID: 34372971

75. Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario J, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin J, Choi J, Santin AD.

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).

Ann Oncol. 2021 Apr 28:S0923-7534(21)01170-4. doi: 10.1016/j.annonc.2021.04.013. Online ahead of print.

PMID: 33932502

74. Benabou K, Khadraoui W, Khader T, Hui P, Fernandez R, Azodi M, Menderes G.

Port-Site Metastasis in Gynecological Malignancies.

JSLS. 2021 Jan-Mar;25(1):e2020.00081. doi: 10.4293/JSLS.2020.00081.

PMID: 33879998

73. Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD.

Integrated mutational landscape analysis of uterine leiomyosarcomas.

Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025182118. doi: 10.1073/pnas.2025182118.

PMID: 33876771

72. Li JY, D’Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S.

Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.

Am J Clin Oncol. 2021 Apr 1;44(4):143-149. doi: 10.1097/COC.0000000000000800.

PMID: 33755031

71. Tymon-Rosario J, Khadraoui W, Nagarkatti N, Menderes G. Robotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer.

Gynecol Oncol Rep. 2020 Nov 10;34:100673. doi: 10.1016/j.gore.2020.100673. eCollection 2020 Nov.

PMID: 33294577

70. Webster EM, Yadav GS, Gysler S, McNamara B, Black J, Tymon-Rosario J, Zeybek B, Han C, Arkfeld CK, Andikyan V, Menderes G, Huang G, Azodi M, Silasi DA, Santin AD, Schwartz PE, Ratner ES, Altwerger G. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study.

Gynecol Oncol Rep. 2020 Nov 2;34:100667. doi: 10.1016/j.gore.2020.100667. eCollection 2020 Nov.

PMID: 33204797

69. Bonazzoli E, Bellone S, Zammataro L, Gnutti B, Guglielmi A, Pelligra S, Nagarkatti N, Manara P, Tymon-Rosario J, Zeybek B, Altwerger G, Menderes G, Han C, Ratner E, Silasi DA, Huang GS, Andikyan V, Azodi M, Schwartz PE, Santin AD. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma. Gynecol Oncol. 2020 Sep;158(3):769-775. doi: 10.1016/j.ygyno.2020.06.484. Epub 2020 Jun 26.

PMID: 32600791

68. Khadraoui W, Tymon-Rosario J, Nagarkatti N, Menderes G. Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence. J Minim Invasive Gynecol. 2020 Jun 13:S1553-4650(20)30296-X. doi: 10.1016/j.jmig.2020.06.006. Online ahead of print.

PMID: 32544562

67. Khadraoui W, Tierney C, Mutlu L, Lu L, Ratner E, Azodi M, Menderes G. Risk Stratifying Clinicopathologic Criteria for Ovarian Preservation in Premenopausal Women with Early Stage Low Risk Endometrial Cancer. Int J Gynaecol Obstet. 2020 Sep;150(3):385-391. doi: 10.1002/ijgo.13254. Epub 2020 Jun 26.

PMID: 32506422

66. Zeybek B, Manzano A, Bianchi A, Bonazzoli E, Bellone S, Buza N, Hui P, Lopez S, Perrone E, Manara P, Zammataro L, Altwerger G, Han C, Tymon-Rosario J, Menderes G, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin A. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Sci Rep. 2020 Jan 22;10(1):973. doi: 10.1038/s41598-020-58009-3.

PMID: 31969666

65. Perrone E, Manara P, Lopez S, Bellone S, Bonazzoli E, Manzano A, Zammataro L, Bianchi A, Zeybek B, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Huang GS, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo. Mol Oncol. 2019 Dec 31. doi: 10.1002/1878-0261.12627. [Epub ahead of print]

PMID: 31891442

64. Han C, Perrone E, Zeybek B, Bellone S, Tymon-Rosario J, Altwerger G, Menderes G, Feinberg J, Haines K, Muller Karger ME, Bianchi A, Zammataro L, Manzano A, Bonazzoli E, Manara P, Buza N, Hui P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Lopez S, Santin AD. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecol Oncol. 2019 Nov 30. pii: S0090-8258(19)31669-5. doi: 10.1016/j.ygyno.2019.11.018. [Epub ahead of print]

PMID: 31839338

63. Zammataro L, Lopez S, Bellone S, Pettinella F, Bonazzoli E, Perrone E, Zhao S, Menderes G, Altwerger G, Han C, Zeybek B, Bianchi A, Manzano A, Manara P, Cocco E, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Angioli R, Raspagliesi F, Scambia G, Choi J, Dong W, Bilguvar K, Alexandrov LB, Silasi DA, Huang GS, Ratner E, Azodi M, Schwartz PE, Pirazzoli V, Stiegler AL, Boggon TJ, Lifton RP, Schlessinger J, Santin AD. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proc Natl Acad Sci U S A. 2019 Oct 17. pii: 201911385. doi: 10.1073/pnas.1911385116. [Epub ahead of print]

PMID: 31624127

62. Mutlu L, Khadraoui W, Khader T, Menderes G. Robotic tumor debulking off external iliac vessels for management of recurrent ovarian cancer. J Minim Invasive Gynecol. 2019 Oct 11. pii: S1553-4650(19)31244-0. doi: 10.1016/j.jmig.2019.10.002. [Epub ahead of print]

PMID: 31610315

61. Bianchi A, Lopez S, Altwerger G, Bellone S, Bonazzoli E, Zammataro L, Manzano A, Manara P, Perrone E, Zeybek B, Han C, Menderes G, Ratner E, Silasi DA, Huang GS, Azodi M, Newberg JY, Pavlick DC, Elvin J, Frampton GM, Schwartz PE, Santin AD. PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.

Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31461-1. doi: 10.1016/j.ygyno.2019.08.010. [Epub ahead of print]

PMID: 31434613

60. Khadraoui W, Zeybek B, Mutlu L, Menderes G. Robotic type II B posterior exenteration for recurrent vaginal cancer. Gynecol Oncol. 2019 Jul 22. pii: S0090-8258(19)31403-9. doi: 10.1016/j.ygyno.2019.07.014. [Epub ahead of print]

PMID: 31345607

59. Seifi F, Parkash V, Clark M, Menderes G, Tierney C, Silasi DA, Azodi M. Pseudovascular Invasion: Minimally Invasive Surgery for Endometrial Cancer.

JSLS. 2019 Apr-Jun;23(2). pii: e2019.00021. doi: 10.4293/JSLS.2019.00021.

PMID: 31285650

58. Menderes G, Gysler SM, Vadivelu N, Silasi DA. Challenges of Robotic Gynecologic Surgery in Morbidly Obese Patients and How to Optimize Success. Curr Pain Headache Rep. 2019 Jul 1;23(7):51. doi: 10.1007/s11916-019-0788-7. Review.

PMID: 31263977

57. Kim S, Chung S, Azodi M, Menderes G. Uterine artery sparing minimally invasive radical trachelectomy: a case report and review of the literature. J Minim Invasive Gynecol. 2019 Jun 4. pii: S1553-4650(19)30259-6. doi: 10.1016/j.jmig.2019.05.017. [Epub ahead of print]

PMID: 31173940

56. Tierney C, Chung SH, Feinberg J, Haines K, Yadav G, Azodi M, Menderes G. A Novel Approach to Combined Vaginal and Laparoscopic Gynecological Surgery. JSLS. 2019 Apr-Jun;23(2). pii: eJSLS.2019.00006. doi: 10.4293/JSLS.2019.00006.

PMID: 31097905

55. Bonazzoli E, Cocco E, Lopez S, Bellone S, Zammataro L, Bianchi A, Manzano A, Yadav G, Manara P, Perrone E, Haines K, Espinal M, Dugan K, Menderes G, Altwerger G, Han C, Zeybek B, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers. Gynecol Oncol. 2019 Apr;153(1):158-164. doi: 10.1016/j.ygyno.2019.01.002. Epub 2019 Jan 7.

PMID: 30630630

54. Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecol Obstet Invest. 2019 Jan 2:1-8. doi: 10.1159/000493132. [Epub ahead of print]

PMID: 30602164

53. Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, Altwerger G, Han C, Manzano A, Bianchi A, Pettinella F, Manara P, Lopez S, Yadav G, Riccio F, Zammataro L, Zeybek B, Yang-Hartwich Y, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Zizioli V, Odicino F, Pecorelli S, Ardighieri L, Silasi DA, Litkouhi B, Ratner E, Azodi M, Huang GS, Schwartz PE, Lifton RP, Schlessinger J, Santin AD. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proc Natl Acad Sci U S A. 2018 Dec 24. pii: 201814027. doi: 10.1073/pnas.1814027116. [Epub ahead of print]

PMID: 30584090

52. Hosier H, Ratner E, Menderes G. Low-Grade Appendiceal Mucinous Neoplasm Diagnosed during Exploratory Laparoscopy for a Presumed Pelvic Mass. J Minim Invasive Gynecol. 2018 Nov 8. pii: S1553-4650(18)31345-1. doi: 10.1016/j.jmig.2018.11.001. [Epub ahead of print]

PMID:30414997

51. Menderes G, Lopez S, Han C, Altwerger G, Gysler S, Varughese J, Schwartz PE, Santin AD. Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it. Discov Med. 2018 Aug;26(141):39-50.

PMID:30265854

50. Altwerger G, Florsheim EB, Menderes G, Black J, Schwab C, Gressel GM, Nelson WK, Carusillo N, Passante T, Huang G, Litkouhi B, Azodi M, Silasi DA, Santin A, Schwartz PE, Ratner ES. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer. J Cancer Res Clin Oncol. 2018 Sep 25. doi: 10.1007/s00432-018-2753-y. [Epub ahead of print]

PMID:30255380

49. Han C, Altwerger G, Menderes G, Haines K, Feinberg J, Lopez S, Manzano A, Varughese J, Santin AD. Novel targeted therapies in ovarian and uterine carcinosarcomas. Discov Med. 2018 Jun;25(140):309-319.

PMID: 30021104

48. Bonazzoli E, Predolini F, Cocco E, Bellone S, Altwerger G, Menderes G, Zammataro L, Bianchi A, Pettinella F, Riccio F, Han C, Yadav G, Lopez S, Manzano A, Manara P, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Schlessinger J, Santin AD. Inhibition of BET bromodomain proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a biologically aggressive variant of Endometrial Cancer. Clin Cancer Res. 2018 Jun 25. pii: clincanres.0864.2018. doi: 10.1158/1078-0432.CCR-18-0864. [Epub ahead of print]

PMID: 29941483

47. Menderes G, Leon-Martinez D, Azodi A. Laparoscopic ligation of uterine vasculature for fertility-sparing management of postabortal hemorrhage. J Minim Invasive Gynecol. 2018 Mar 30. pii: S1553-4650(18)30177-8. doi: 10.1016/j.jmig.2018.03.020. [Epub ahead of print]

PMID:29609031

46. Han C, Bellone S, Siegel ER, Altwerger G, Menderes G, Bonazzoli E, Egawa-Takata T, Pettinella F, Bianchi A, Riccio F, Zammataro L, Yadav G, Marto JA, Penet MF, Levine DA, Drapkin R, Patel A, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma. Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30230-0. doi: 10.1016/j.ygyno.2018.03.050. [Epub ahead of print]

PMID:29572027

45. Altwerger G, Bonazzoli E, Bellone S, Egawa-Takata T, Menderes G, Pettinella F, Bianchi A, Riccio F, Feinberg J, Zammataro L, Han C, Yadav G, Dugan K, Morneault A, Ponte JF, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD. In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers. Mol Cancer Ther. 2018 Feb 13. pii: molcanther.0930.2017. doi: 10.1158/1535-7163.MCT-17-0930. [Epub ahead of print]

PMID: 29440294

44. Albright BB, Black JD, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Buza N, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecol Oncol Rep. 2018 Jan 9;23:28-33. doi: 10.1016/j.gore.2018.01.003. eCollection 2018 Feb.

PMID: 29387776

43. Kim S, Menderes G, Hill A, Cross S, Azodi M, Bahtiyar O. Minimally invasive abdominal cerclage compared to laparotomy: A comparison of surgical and obstetric outcomes. J Robot Surg. 2017 Jul 18. doi: 10.1007/s11701-017-0726-9. [Epub ahead of print]

PMID:28721634

42. Menderes G, Bonazzoli E, Bellone S, Altwerger G, Black J, Dugan K, Pettinella F, Masserdotti A, Riccio F, Bianchi A, Zammataro L, deHaydu C, Buza N, Hui P, Wong S, Huang G, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression. Gynecol Oncol. 2017 Jul 10. pii: S0090-8258(17)31026-0. doi: 10.1016/j.ygyno.2017.07.009. [Epub ahead of print]

PMID:28705408

41. Menderes G, Bonazzoli E, Bellone S, Black J, Predolini F, Pettinella F, Masserdotti A, Zammataro L, Altwerger G, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression. Clin Cancer Res. 2017 Jul 5. pii: clincanres.2862.2016. doi: 10.1158/1078-0432.CCR-16-2862. [Epub ahead of print]

PMID:28679774

40. Menderes G, Nhundu B, Levy K, Silasi DA. Robotic Resection of Symptomatic Parasitic Leiomyoma From Obturator Fossa. J Minim Invasive Gynecol. 2017 Jul 7. pii: S1553-4650(17)30312-6. doi: 10.1016/j.jmig.2017.05.018. [Epub ahead of print]

PMID: 28689655

39. Menderes G, Dugan K, Klein M, Azodi M. Natural Orifice Assisted Laparoscopic Meckel Diverticulectomy Incidentally Found During a Para-aortic Mass Resection. J Minim Invasive Gynecol. 2017 May 3. pii: S1553-4650(17)30281-9. doi: 10.1016/j.jmig.2017.04.015. [Epub ahead of print]

PMID:28478192

38. Menderes G, Bonazzoli E, Bellone S, Black J, Altwerger G, Masserdotti A, Pettinella F, Zammataro L, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang G, Azodi M, Schwartz PE, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Promising Antitumor Activity in Epithelial Ovarian Carcinoma with HER2/Neu Expression. Gynecol Oncol. 2017 Jul;146(1):179-186. doi: 10.1016/j.ygyno.2017.04.023. Epub 2017 May 1.

PMID:28473206

37. Whicker M, Black J, Altwerger G, Menderes G, Feinberg J, Ratner E. Management of Sexuality, Intimacy, and Menopause Symptoms (SIMS) in Ovarian Cancer Patients: Expert Review. Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30513-6. doi: 10.1016/j.ajog.2017.04.012. [Epub ahead of print] Review.

PMID: 28411144

36. Menderes G, Bonazzoli E, Bellone S, Black JD, Lopez S, Pettinella F, Masserdotti A, Zammataro L, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo. Med Oncol. 2017 May;34(5):91. doi: 10.1007/s12032-017-0956-8. Epub 2017 Apr 10.

PMID: 28397106

35. Cocco E, Deng Y, Shapiro EM, Bortolomai I, Lopez S, Lin K, Bellone S, Cui J, Menderes G, Black JD, Schwab CL, Bonazzoli E, Yang F, Predolini F, Zammataro L, Altwerger G, de Haydu C, Clark M, Alvarenga J, Ratner E, Azodi M, Silasi DA, Schwartz PE, Litkouhi B, Saltzman WM, Santin AD. Dual-targeting nanoparticles for in vivo delivery of suicide genes to chemotherapy-resistant ovarian cancer cells. Mol Cancer Ther. 2017 Feb;16(2):323-333. doi: 10.1158/1535-7163.MCT-16-0501.

PMID: 27956521

34. Zeybek B, Hill A, Menderes G, Borahay MA, Azodi M, Kilic GS. Robot-Assisted Abdominal Cerclage During Pregnancy. JSLS. 2016 Oct-Dec;20(4). pii: e2016.00072.

PMID:27904309

33. Bellone S, Bignotti E, Lonardi S, Ferrari F, Centritto F, Masserdotti A, Pettinella F, Black J, Menderes G, Altwerger G, Hui P, Lopez S, de Haydu C, Bonazzoli E, Predolini F, Zammataro L, Cocco E, Ferrari F, Ravaggi A, Romani C, Facchetti F, Sartori E, Odicino FE, Silasi DA, Litkouhi B, Ratner E, Azodi M, Schwartz PE, Santin AD. Polymerase <epsilon> (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31579-7. doi: 10.1016/j.ygyno.2016.11.023.

PMID: 27894751

32. Altwerger G, Menderes G, Black JD, Azodi M. Should we continue intra-peritoneal chemotherapy for advanced ovarian cancer patients? Integrative Cancer Science and Therapeutics. Accepted September 2016.

31. Altwerger G, Menderes G, Black JD, Azodi M. Surgical site infections in gynecologic oncology. Gynecology & Obstetrics Journal. Accepted September 2016.

30. Menderes G, Schwab CL, Black JD, Azodi M. Cervical injection of methylene blue for identification of sentinel lymph nodes in cervical cancer. OBG Manag. 2016 August;28(8):16.

29. Menderes G, Black JD, Azodi M. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer. Expert Rev Anticancer Ther. 2016 Sep;16(9):899-901. doi: 10.1080/14737140.2016.1219658. Epub 2016 Aug 9.

PMID: 27477495

28. Cocco E, Lopez S, Black J, Bellone S, Bonazzoli E, Predolini F, Ferrari F, Schwab CL,Menderes G, Zammataro L, Buza N, Hui P, Wong S, Zhao S, Bai Y, Rimm DL, Ratner E, Litkouhi B, Silasi DA, Azodi M, Schwartz PE, Santin AD. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1 amplified/PIK3CA mutated uterine serous carcinomas in vitro and in vivo. Br J Cancer. 2016 Jul 26;115(3):303-11. doi: 10.1038/bjc.2016.198. Epub 2016 Jun 28.

PMID:27351214

27. Black J, Menderes G, Bellone S, Schwab CL, Bonazzoli E, Ferrari F, Predolini F, De Haydu C, Cocco E, Buza N, Hui P, Wong S, Lopez S, Ratner E, Silasi DA, Azodi M, Litkouhi B, Schwartz PE, Goedings P, Beusker PH, van der Lee MM, Timmers CM, Dokter WH, Santin AD. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression.Br J Cancer. 2016 Jul 26;115(3):303-11. doi: 10.1038/bjc.2016.198. Epub 2016 Jun 28.

PMID: 27351214

26. Menderes G, Vilardo N, Schwab CL, Azodi M. Incidental Injury and Repair of Obturator Nerve During Laparoscopic Pelvic Lymphadenectomy. Gynecol Oncol. 2016 Jul;142(1):208. doi: 10.1016/j.ygyno.2016.05.023. Epub 2016 May 27.

PMID: 27234143

25. English DP, Menderes G, Black J, Schwab CL, Santin AD. Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer. Expert Rev Mol Diagn. 2016 Jul;16(7):769-82. doi: 10.1080/14737159.2016.1188692. Epub 2016 May 27.

PMID:27169329

Menderes G, Hicks C, Black JD, Schwab CL, Santin AD. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.Expert Opin Biol Ther. 2016 Aug;16(8):989-1004. doi: 10.1080/14712598.2016.1177018. Epub 2016 Apr 25. Review.

PMID:27070175

24. Menderes G, Clark M, Santin AD. Novel Targeted Therapies in Uterine Serous Carcinoma, an Aggressive Variant of Endometrial Cancer. Discov Med. 2016 Apr;21(116):293-303.

PMID: 27232515

23. Menderes G, English DP, Schwab CL, Santin AD. Important Molecular Advances in Diagnosis and Management of Uterine Serous Carcinoma: A Review. Curr Probl Cancer. Accepted in January 2016, pending publication.

22. Menderes G, Schwab CL, Black J, Santin DA. The Role of the Immune System in Ovarian Cancer and Implications on Therapy. Expert Rev Clin Immunol. 2016 Jun;12(6):681-95. doi: 10.1586/1744666X.2016.1147957. Epub 2016 Feb 15.

PMID:26821930

21. Menderes G, Schwab CL, Black J, Silasi DA. Laparoscopic Resection of The Diaphragmatic Tumor Nodule for Management of Recurrent Endometrial Cancer. J Minim Invasive Gynecol. 2016 May-Jun;23(4):473-4. doi: 10.1016/j.jmig.2016.01.006. Epub 2016 Jan 8.

PMID: 26776674

20. Kakar F, English D, Menderes G, Azodi M. Laparoscopic Ovarian Transposition. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S153. doi: 10.1016/j.jmig.2015.08.566. Epub 2015 Oct 15.

PMID:27678870

19. Zigras T, Goodman L, Menderes G, Azodi M. Comparison of Robotics Versus Conventional Laparoscopy for Management of Benign Adnexal Masses. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S22-S23. doi: 10.1016/j.jmig.2015.08.069. Epub 2015 Oct 15.

PMID: 27679091

18. Clark M, Glasgow M, Menderes G, Azodi M, Silasi DA. Early Stage Uterine Serous Carcinoma: Does Surgical Approach Impact Survival? J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S48-S49. doi: 10.1016/j.jmig.2015.08.134. Epub 2015 Oct 15.

PMID: 27679256

17. Menderes G, Black J, Schwab CL, Santin AD. Immunotherapy and targeted therapy for cervical cancer: an update. Expert Rev Anticancer Ther. 2016;16(1):83-98. doi: 10.1586/14737140.2016.1121108. Epub 2015 Dec 7. Review.

PMID:26568261

16. Ferrari F, Bellone S, Black J, Schwab CL, Lopez S, Cocco E, Bonazzoli E, Predolini F, Menderes G, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. J Exp Clin Cancer Res. 2015 Oct 17;34:123. doi: 10.1186/s13046-015-0241-7.

PMID:26474755

15. O’Sullivan R, Clark M, Friedman P, Sauer C, Menderes G. Rupture of the unscarred gravid uterus: Case series. Journal of Medical Cases. Accepted June 2, 2015.

14. Menderes G, Clark M, Tower A, Azodi M. External iliac vein injury and repair during robotic-assisted pelvic lymphadenectomy. J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):718. 

PMID:25888352

13. Menderes G, Clark M, Clark-Donat L, Azodi M. Robotic-assisted abdominal cerclage placement during pregnancy and its challenges: Video Article. J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):713-4.

PMID:25772022

12. English D, Menderes G, Azodi M. Controlled removal of a large uterus within a bowel bag and morcellation in the bowel bag from the vagina. Gynecol Oncol. 2015 Jun;137(3):589-90. 

PMID:25797081

11. Clark-Donat L, Clark M, Menderes G, Tower A, Parkash V, Silasi DA, Azodi M. Transvaginal morcellation. JSLS. 2015 Apr-Jun;19(2).

PMID:26005318

10. Clark-Donat L, Menderes G, Tower A, Silasi DA, Azodi M. A simple approach to specimen retrieval via posterior colpotomy incision. JSLS. 2015 Apr-Jun;19(2).

PMID:25901107

9. Clark-Donat L, Menderes G, Tower A, Azodi M. A Technique for Vascular Control During Robotic-Assisted Laparoscopic Myomectomy. J Minim Invasive Gynecol. 2015 May-Jun;22(4):543.

PMID:25680685

8. Menderes G, Clark L, Azodi M. Needleless Laparoscopic Abdominal Cerclage Placement. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):321.

PMID:25489676

7. Menderes G, Clark-Donat L, Azodi M. Incidental Ureteral Injury and Repair During Robotic-Assisted Total Laparoscopic Hysterectomy. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):320.

PMID:25461686

6. Menderes G, Silasi DA. Robotic Resection of Bulky Aorto-Caval Lymphadenopathy in a Patient with Serous Fallopian Tube Carcinoma Gynecol Oncol. 2015 Jan;136(1):172-3.

PMID:25449567

5. Menderes G, Azodi M, Schwartz P, Silasi DA. Comparison of Lower Extremity Lymphedema Incidence Between Two Pelvic Lymphadenectomy Techniques in Uterine Cancer Patients Undergoing Robotic-Assisted Staging Procedures. Int J Gynecol Cancer. 2015 Jan;25(1):160-5.

PMID:25386859

4. Menderes G, Silasi DA. Robotic Resection of Gastro-Splenic Ligament Tumor in a Patient with Recurrent Uterine Serous Carcinoma. J Robot Surg. JORS-D-14-00059R2. Accepted for publication 2014, October 5

3. Menderes G, Azodi M, Clark L, Xu X, Lu L, Santin A, Ratner E, Schwartz P, Rutherford T, Silasi D. Impact of Body Mass Index on Outcomes of Endometrial Cancer Patients Undergoing Robotic-Assisted Staging and Analysis of Disease Recurrence. . Int J Gynecol Cancer. 2014 Jul;24(6):1118-25.

PMID:24927247

2. Menderes G, Clark L, Azodi M. Robotic-Assisted Abdominal Cerclage Placement During Pregnancy: A Case Report and Literature Review.J Robot Surg. 2014 Sep;8(3):195-200. doi: 10.1007/s11701-014-0462-3. Epub 2014 Apr 30. Review.

PMID:27637677

Silasi DA, Gallo T, Silasi M, Menderes G, Azodi M. Robotic versus Abdominal Hysterectomy for Very Large Uteri. . JSLS. 2013 Jul-Sep;17(3):400-6.

PMID:24018076

1. Menderes G, Athar Ali N, Aagaard K, Sangi-Haghpeykar H. Chlorhexidine-Alcohol Compared with Povidone-Iodine for Surgical-Site Antisepsis in Cesarean Deliveries. Obstet Gynecol. 2012 Nov;120(5):1037-44.

PMID:23090520